Navigation Links
Hormone Shows Potential as Diabetes Treatment in Mice
Date:4/25/2013

THURSDAY, April 25 (HealthDay News) -- A hormone that could lead to more effective diabetes treatment has been identified by researchers.

The hormone, called betatrophin, causes mice to produce insulin-secreting pancreatic beta cells at up to 30 times the normal rate. But it only produces insulin when the body needs it, according to the team at the Harvard Stem Cell Institute.

The researchers said their findings offer the potential for the natural regulation of insulin and a significant reduction in diabetes-related complications such as blindness and limb amputation.

The study is published in the April 25 online edition of the journal Cell and in its May 9 print issue.

Although the hormone shows promise in lab mice, much more work is needed before it could be considered as a treatment for diabetes in humans, the researchers noted. Results obtained in animal experiments often aren't attainable in trials with humans.

"If this could be used in people, it could eventually mean that instead of taking insulin injections three times a day, you might take an injection of this hormone once a week or once a month, or in the best case maybe even once a year," Doug Melton, co-director of the institute and co-chair of Harvard University's department of stem cell and regenerative biology, said in a university news release.

About 26 million Americans have type 2 diabetes, which causes people to slowly lose beta cells and the ability to produce sufficient amounts of insulin.

"Our idea here is relatively simple," Melton said. "We would provide this hormone, the type 2 diabetic will make more of their own insulin-producing cells, and this will slow down, if not stop, the progression of their diabetes. I've never seen any treatment that causes such an enormous leap in beta cell replication."

Along with its potential for treating type 2 diabetes, betatrophin might also have a role in treating type 1 diabetes, Melton said.

Unlike type 2 diabetes, which is associated with being overweight and sedentary, type 1 diabetes is an autoimmune disease that occurs most often in children and young adults.

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases has more about diabetes.

-- Robert Preidt

SOURCE: Harvard University, news release, April 25, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Hormones For Weight Control Article And Video Published by BetterDigestion.org
2. Researchers identify and block protein that interferes with appetite-suppressing hormone
3. Intermittent Hormone Treatment for Prostate Cancer Not the Best
4. Study Suggests Link Between Hormone Melatonin and Type 2 Diabetes
5. Princess Margaret breast cancer research finds new drug target companion prognostic test for hormone therapy resistance
6. More Evidence Shows Hormone Therapy May Increase Breast Cancer Risk
7. Artificial Ovaries Could Potentially Deliver Hormone Therapy
8. Mindfulness from meditation associated with lower stress hormone
9. Should Short Boys Take Growth Hormone?
10. Hormone Pills in Menopause May Carry Gallstone Side Effects
11. Study examines outcomes of screening mammography for age, breast density, hormone therapy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hormone Shows Potential as Diabetes Treatment in Mice
(Date:5/6/2016)... ... ... Mother’s Day is mixed with worry and fear for new mothers those whose babies are ... first time ever, the March of Dimes and Random Acts of Flowers ... crib surrounded by lifesaving equipment or peering through a glass window at a baby they ...
(Date:5/6/2016)... ... May 06, 2016 , ... ... Service, their latest implementation service offering for global clients of Coupa ( Coupa ... , Bluvault’s Integration Service is a key component in the suite of ...
(Date:5/6/2016)... ... 06, 2016 , ... Online HR/benefits platforms offer a range of benefits functions ... brokers and health plans. “ The Rapid Emergence of Online Benefits Firms: Strategies for ... Inc. (AIS), will offer an accurate picture of online benefits today, and the possible ...
(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... The International ... Resort on the north end of the island close to the town famous for ... August 10th 2016. , “We continue to have an amazing experience in Greece, ...
(Date:5/6/2016)... ... May 06, 2016 , ... Few events ... made headlines mostly for its cost despite its potential to wipe out a ... the drug—part of a class called direct-acting antivirals (DAAs)—have created fallout in the ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... DUBLIN, May 5, 2016 , First ... and revenues of $964 million , First ... of $0.40 , Company revises 2016 financial ... to $4.03 billion and 2016 adjusted diluted non-GAAP earnings per ... Company provides updates regarding Generics business and manufacturing facility ...
(Date:5/5/2016)... 2016 Research and Markets has announced the ... 5 EU Markets"  report to their offering.  ,     (Logo: ... on the current Positron Emission Tomography (PET) scanner and cyclotron ... which includes France , Germany ... and the United Kingdom . ...
(Date:5/5/2016)... May 5, 2016 ... the  "Europe Systemic Lupus Erythematosus Market and ... their offering.       (Logo: ... research Europe Systemic Lupus Erythematosus Market and ... insights into Systemic Lupus Erythematosus pipeline products, ...
Breaking Medicine Technology: